Dr Richard Armer
Chief Scientific Office
United Arab Emirates
Richard Armer joined Redx in 2012, becoming Chief Scientific Officer in 2014. He has significant experience in both small biotechnology and large pharmaceutical companies through his roles within Pfizer
Organon, Ardana, Oxagen, Lectus Therapeutics. Richard’s expertise is in drug discovery with a particular focus on lead optimisation activities, drug disposition, intellectual property and commercial scientific project positioning. He has experience across a wide range of therapeutic areas and has been successful in generating and progressing multiple clinical candidates.